Andrew M Tometsko, Deceased

Title: The Innovations of Andrew M. Tometsko

Introduction

Andrew M. Tometsko was a notable inventor whose contributions to the field of medical technology have left a lasting impact. He is best known for his innovative work in the lyophilization of red blood cells, which has significant implications for blood storage and transfusion practices. His dedication to advancing medical science is reflected in his patent and collaborations with esteemed colleagues.

Latest Patents

Tometsko held a patent for a "Method and composition for lyophilizing red blood cells." This patent discloses a composition for the lyophilization of mammalian red blood cells, which includes a hydrophilic polymer, a carbohydrate, and an organic solvent. The method involves mixing red blood cells with the composition, freezing the mixture, and drying it by removing water through sublimation. The patent also details the specific components of the composition, including a hydrophilic polymer ranging from 1,450-20,000 Daltons at 5-50% w/v, and a mono- or disaccharide from 0.01-0.2M, along with an organic solvent at 0.5-20% v/v.

Career Highlights

Throughout his career, Tometsko worked at Litron Laboratories Ltd., where he focused on developing innovative solutions for blood preservation. His work has been instrumental in improving the safety and efficacy of blood transfusions, ultimately benefiting patients in need of blood products.

Collaborations

Tometsko collaborated with several notable individuals in his field, including Stephen D. Dertinger and Dorothea K. Torous. These collaborations helped to enhance the research and development of his patented methods.

Conclusion

Andrew M. Tometsko's contributions to the field of medical technology, particularly in the lyophilization of red blood cells, demonstrate his commitment to innovation and improving healthcare practices. His legacy continues to influence the medical community today.